Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5626
PUT
National Beverage
FIZZ
$3.01B
| $1.01M | ﹤0.01% |
33,200
+17,400
| +110% | +$470K |
|
|
VIRX
5627
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.01M | ﹤0.01% |
109,933
+6,969
| +7% | +$105K |
|
|
PPLC
5628
DELISTED
PortfolioPlus S&P 500 ETF
PPLC
| $1.01M | ﹤0.01% |
24,554
-6,848
| -22% | -$264K |
|
5629
iShares Genomics Immunology and Healthcare ETF
IDNA
$205M
| $1.01M | ﹤0.01% |
+26,651
| New | +$900K |
|
5630
PUT
MSC Industrial Direct
MSM
$6.86B
| $1.01M | ﹤0.01% |
13,900
-800
| -5% | -$51.6K |
|
|
BBU
5631
DELISTED
Brookfield Business Partners
BBU
| $1.01M | ﹤0.01% |
51,123
+8,136
| +19% | +$157K |
|
|
PLAN
5632
DELISTED
Anaplan, Inc.
PLAN
| $1.01M | ﹤0.01% |
22,332
-1,486,557
| -99% | -$62.2M |
|
5633
Boot Barn
BOOT
$4.95B
| $1.01M | ﹤0.01% |
46,834
+35,276
| +305% | +$690K |
|
5634
ProShares Ultra Russell2000
UWM
$245M
| $1.01M | ﹤0.01% |
41,578
-161,162
| -79% | -$3.37M |
|
5635
PUT
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $1.01M | ﹤0.01% |
20,300
-3,800
| -16% | -$187K |
|
5636
CALL
Opko Health
OPK
$1.02B
| $1.01M | ﹤0.01% |
295,600
+143,900
| +95% | +$322K |
|
5637
Puma Biotechnology
PBYI
$454M
| $1.01M | ﹤0.01% |
96,605
-147,463
| -60% | -$1.53M |
|
|
WMGI
5638
PUT
DELISTED
Wright Medical Group Inc
WMGI
| $1.01M | ﹤0.01% |
33,900
+13,200
| +64% | +$386K |
|
5639
CALL
Affiliated Managers Group
AMG
$9.76B
| $1.01M | ﹤0.01% |
13,500
-2,100
| -13% | -$142K |
|
5640
CALL
SouthState Bank Corp
SSB
$10.5B
| $1.01M | ﹤0.01% |
+21,100
| New | +$1.1M |
|
5641
Invesco Building & Construction ETF
PKB
$399M
| $1M | ﹤0.01% |
32,985
-59,500
| -64% | -$1.58M |
|
5642
Regional Management Corp
RM
$303M
| $1M | ﹤0.01% |
56,663
-20,231
| -26% | -$316K |
|
5643
Service Corp International
SCI
$11.6B
| $1M | ﹤0.01% |
25,815
-35,519
| -58% | -$1.36M |
|
5644
CALL
Magnachip Semiconductor
MX
$145M
| $1M | ﹤0.01% |
97,400
-4,900
| -5% | -$54.6K |
|
5645
CALL
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.7M
| $1M | ﹤0.01% |
7,450
-6,775
| -48% | -$907K |
|
|
TRUE
5646
DELISTED
TrueCar
TRUE
| $1M | ﹤0.01% |
388,491
+39,515
| +11% | +$101K |
|
5647
Vishay Precision Group
VPG
$914M
| $1M | ﹤0.01% |
40,756
+12,136
| +42% | +$273K |
|
|
UCB
5648
United Community Banks
UCB
$4.28B
| $1M | ﹤0.01% |
49,772
-22,160
| -31% | -$424K |
|
5649
PUT
AES
AES
$10.5B
| $1M | ﹤0.01% |
69,000
+18,600
| +37% | +$244K |
|
5650
Arcutis Biotherapeutics
ARQT
$3.18B
| $1M | ﹤0.01% |
33,089
-22,476
| -40% | -$650K |
|
Similar funds
Citadel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.
- Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
- Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.